triptonide has been researched along with Germinoblastoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, F; Yang, P; Zhou, Q | 1 |
1 other study(ies) available for triptonide and Germinoblastoma
| Article | Year |
|---|---|
Triptonide acts as a novel potent anti-lymphoma agent with low toxicity mainly through inhibition of proto-oncogene Lyn transcription and suppression of Lyn signal pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Jurkat Cells; Lymphoma; Mice, Inbred NOD; Mice, SCID; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins c-akt; Signal Transduction; src-Family Kinases; Time Factors; Transcription, Genetic; Triterpenes; Xenograft Model Antitumor Assays | 2017 |